38 /100
MEDIUM RISK
Score updated Jul 14, 2026

FOLD — Amicus Therapeutics Inc Dilution Risk Tracker

Track FOLD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FOLD — Get alerts when the score changes →

As of July 14, 2026, Amicus Therapeutics Inc (FOLD) has a DilutionWatch DilutionScore of 38/100, rated MEDIUM dilution risk. Amicus Therapeutics Inc has a market capitalization of $4.55B, 314.00M shares outstanding, 304 institutional holders tracked. Key dilution vectors include 1.60M outstanding warrants, approximately 36 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FOLD.
🔔 Track FOLD — Get forecast alerts →

💹 Market Data

Market Cap$4.55B
Shares Outstanding314.00M
Float311.44M
Cash$293.54M
Debt$392.66M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.9% shares (2026Q1 vs prior)
304 institutional holders · 375.07M shares
#1 BlackRock, Inc. 33.88M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 28.05M shares
#3 GOLDMAN SACHS GROUP INC 17.70M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest21.92M
Days to Cover7.5
% of Float7.0%
FINRA data as of Apr 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
EFFECT EFFECT Apr 29, 2026
EFFECT EFFECT Apr 29, 2026
EFFECT EFFECT Apr 29, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for FOLD Shareholders

Amicus Therapeutics Inc (FOLD) has a DilutionScore of 38/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 1.6M outstanding warrants for FOLD. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for FOLD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for FOLD alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track FOLD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FOLD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for FOLD
📊 FOLD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FOLD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.